HomeMarketsSharesOscar Health, Inc.

Trade Oscar Health, Inc. - OSCR CFD

Market is not available at the momentMarket information is presented
as of 2026-10-16T20:45:27+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.44
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02224 %
(-$4.45)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02224%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00001 %
($0.00)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


0.00001%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close32.75
Open32.75
1-Year Change59.29%
Day's Range31.66 - 33.43

Trade Oscar Health, Inc. - OSCR

Check out our live chart to get all the information you need on the Oscar Health stock price today

Oscar Health (OSCR) is a technology-led health insurance provider based in the US. The company combines its technology platform with a personalised, consumer-focused approach to healthcare services. 

Oscar Health’s mobile app and website allow users to sign up for and manage their health insurance, doctor appointments, prescriptions and other care options online, and a dedicated care team provides tailored guidance. The firm sells health insurance plans with tiered premiums, allowing customers to select the plan that most suits their needs.

Oscar Health Insurance Co. (OSCR) stock was listed publicly in March 2021, with the company’s shares now trading on the New York Stock Exchange (NYSE).

Join Capital.com today to stay up to date with the company’s latest news and follow the Oscar Health share price quote live.

One of the companies leading the charge in rolling out telemedicine services in the US, Oscar Health was founded in 2012 by Joshua Kushner (the brother of Jared Kushner, former US president Donald Trump’s son-in-law), Mario Schlosser and Kevin Nazemi, who is no longer with the business. The firm changed its name from Mulberry Health in January 2021.

Since 2017, the company has grown from 15,000 members in one state to 529,000 members in 18 states, and it plans to expand into new areas to tap into the growing US healthcare industry.

The healthcare landscape in the US is complex and undergoing a transition to incorporate digital experiences and customer engagement. Although there are opportunities for growth as healthcare spending continues to increase, the industry is highly competitive. Oscar Health made a loss of $406.8m in 2020, up from $259.4m in 2019, while its revenues fell to $462.8m from $488.2m.

With Capital.com’s comprehensive OSCR stock chart, you can view the company’s current share price and track the performance of the stock since its listing.

Oscar Health held its initial public offering (IPO) on March 3, 2021. Ahead of the listing, the company increased the number of shares on offer as well as their price, reflecting strong interest among investors in telemedicine IPOs. In the offering, the business sold 37 million shares at $39 each, raising nearly $1.44bn. The stock started trading at $36 per share and closed its first day on the NYSE at $34.80 per share.

Are you looking to trade the stock right now? You can go long or short on the company’s shares and trace all the latest ups and downs of the Oscar Health (OSCR) share price using Capital.com’s proprietary CFD trading platform.

Latest shares articles

BAE Systems stock forecast
BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026
TAURON stock forecast
TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026
Puma stock forecast
Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Dino Polska stock forecast
Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready